Over 6 million people suffer from painful diabetic foot pain in the US alone, causing pain or weakness in their feet and legs.¹⁻²
Diabetic foot pain can be associated for diabetic peripheral neuropathy (DPN) this can be treated with a small implanted device to help interrupt pain signals. It's been proven to provide meaningful long-lasting pain relief of up to 10 years for moderate-to-severe DPN.³
Take the survey to see if this therapy could be right for you.
Farrah was diagnosed with painful diabetic peripheral neuropathy, a condition that may affect the legs and feet of people with diabetes. See how this therapy helped to relieve her pain and enable to to return to every day living.
Potential benefits of SCS therapy
Multiple studies have found that spinal cord stimulation (SCS) significantly reduces DPN pain, provides lasting relief, and provides better results for most patients compared to other treatments such as medication.
People with DPN are 17 times more likely to experience significant pain relief
86% experienced treatment success after receiving SCS therapy for 1 year
>50% of patients still experiencing clinically meaningful pain relief up to 10 years
Take a short survey to see if the small implantable device may be right for you.
*Success rates in a population of patients treated with SCS in two studies and followed for up to 10 years.
Understand the risks
Not everyone responds to SCS in the same way, and your experience may vary. Risks include infection, lead movement, pain at the implant site, and loss of therapy eﬀectiveness. Please discuss in detail with your doctor. Patients with diabetes may have an increased risk for surgical complications. Talk to your doctor about your ability to undergo surgery. Please check with your insurance company for specific coverage to your health plan.
When certain criteria are met, Medicare covers the trial and implantation of a spinal cord stimulator (SCS) when prescribed by your health care provider to treat diabetic peripheral neuropathy (DPN). Commercial and other insurance coverage varies depending on your plan. Your physician is encouraged, and may even be required, to obtain approval from your insurance company before proceeding with the procedure. We recommended that your physician verifies your insurance company’s SCS medical policy prior to scheduling a trial procedure.
Can I receive an MRI if I have the device implanted?
Medtronic offers full-body MRI access on all SCS devices*. Your Medtronic SCS device will never hold you back from getting a scan anywhere on your body if you need it.
*Under specific conditions. Refer to product labeling for a full list of conditions
Will the implanted device give me the same pain relief as the trial?
The trial is designed to mimic what you will experience with the implanted device. Once you have the implant, your doctor will adjust the therapy to optimize your pain relief.
Can I control the stimulation?
Your doctor will initially program the stimulator settings based on your needs and preferences, but you will be able to make adjustments with your handheld programmer.
1. CDC national diabetes specific report, accessed on August 29, 2023. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf#page=5
2. Veves A, Backonja M, Malik RA. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med. 2008 Sep;9(6):660-74.
3. Zuidema X, et al. Long-term evaluation of spinal cord stimulation in patient with painful diabetic polyneuropathy: an eight-to-ten-year prospective cohort study. Neuromodulation 2022;1-7.
4. Slangen R, Schaper NC, Faber CG, et al. Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care. 2014 Nov;37(11):3016-24.
5. de Vos CC, Meier K, Zaalberg PB, et al. Spinal cord stimulation in patients with painful diabetic neuropathy: A multicenter randomized clinical trial. Pain. 2014;155(11):2426–2431. doi:10.1016/j.pain.2014.08.031.
6. Medtronic Pain Therapy Clinical Summary M221494A016 Rev B. United States; 2022.
7. van Beek M, Geurts JW, Slangen R, et al. Severity of neuropathy is associated with long-term spinal cord stimulation outcome in painful diabetic peripheral neuropathy: Five-year follow-up of a prospective two-center clinical trial. Diabetes Care. 2018;41(1):32–38. doi:10.2337/dc17-0983.
Important Safety Information: Spinal Cord Stimulation
Spinal cord stimulation (SCS) is indicated as an aid in the management of chronic, intractable pain of the trunk and/or limbs-including unilateral or bilateral pain.
Diathermy - Energy from diathermy can be transferred through the implanted system and cause tissue damage resulting in severe injury or death.
Sources of electromagnetic interference (e.g., defibrillation, electrocautery, MRI, RF ablation, and therapeutic ultrasound) can interact with the system, resulting in unexpected changes in stimulation, serious patient injury or death. An implanted cardiac device (e.g., pacemaker, defibrillator) may damage a neurostimulator, and electrical pulses from the neurostimulator may cause inappropriate response of the cardiac device. Diabetic patients may have more frequent and severe complications with surgery. A preoperative assessment is advised for some diabetic patients to confirm they are appropriate candidates for surgery.
Safety and effectiveness has not been established for pediatric use, pregnancy, unborn fetus, or delivery. Avoid activities that put stress on the implanted neurostimulation system components. Recharging a rechargeable neurostimulator may result in skin irritation or redness near the implant site.
May include: undesirable change in stimulation (uncomfortable, jolting or shocking); hematoma, epidural hemorrhage, paralysis, seroma, infection, erosion, device malfunction or migration, pain at implant site, loss of pain relief, and other surgical risks. Adverse events may result in fluctuations in blood glucose in diabetic patients. Refer to www.medtronic.com for product manuals for complete indications, contraindications, warnings, precautions and potential adverse events. Rx only. Rev 0422